Lv2
104 积分 2024-11-11 加入
An updated patent review of EZH2 inhibitors (2024 – present)
1个月前
已关闭
Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA
1个月前
已完结
Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development
1个月前
已完结
Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors
1个月前
已完结
Formaldehyde-Mediated Hydride Liberation of Alkylamines for Intermolecular Reactions in Hexafluoroisopropanol
1个月前
已完结
Construction of Complex Macromulticyclic Peptides via Stitching with Formaldehyde and Guanidine
1个月前
已完结
Peptide Stapling by Crosslinking Two Amines with α‐Ketoaldehydes through Diverse Modified Glyoxal‐Lysine Dimer Linkers
1个月前
已完结
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
2个月前
已完结
Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas
3个月前
已完结
Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas
3个月前
已完结
NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis
皖公网安备34019202002308
